Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma – Effectiveness and treatment reality of the European multi-centric, multi-national, non-interventional study: BERING CRC

15. Januar 2026

S. Stintzing, H. Müller-Huesmann, E. von der Heyde, I. Virchow, R. Greil, J. Kisro, P. Stübs, D. Buerkle, A. Distelrath, J. Wierecky, A. Wein, A. Gerger, D. Arnold, R.M. Fritsch, S. Hegewisch-Becker, A. Vogel, A.D. Wagner, T. Winder, D. Koeberle, G. Prager.

Annals of Oncology, Volume 36, Supplement 1, 2025, Page S25, https://doi.org/10.1016/j.annonc.2025.05.052.

Poster